A detailed history of Guardian Wealth Management, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Guardian Wealth Management, Inc. holds 230 shares of VTRS stock, worth $2,684. This represents 0.0% of its overall portfolio holdings.

Number of Shares
230
Previous 230 -0.0%
Holding current value
$2,684
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$8.77 - $10.85 $1,780 - $2,202
203 Added 751.85%
230 $2,000
Q3 2023

Oct 31, 2023

BUY
$9.59 - $11.35 $9 - $11
1 Added 3.85%
27 $0
Q4 2022

Feb 10, 2023

BUY
$8.72 - $11.56 $8 - $11
1 Added 4.0%
26 $0
Q3 2022

Nov 14, 2022

SELL
$8.48 - $11.13 $76 - $100
-9 Reduced 26.47%
25 $0
Q2 2022

Aug 15, 2022

BUY
$9.95 - $12.27 $9 - $12
1 Added 3.03%
34 $0
Q4 2021

Feb 15, 2022

BUY
$12.09 - $14.68 $398 - $484
33 New
33 $0

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Guardian Wealth Management, Inc. Portfolio

Follow Guardian Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Guardian Wealth Management, Inc. with notifications on news.